Novartis specialises in clinical research and development of innovative drugs and in exploring new methods of treatment. With its a broad range of innovations, Novartis ranks among leaders in the global pharmaceutical industry.
Novartis is a unique group of companies which are each at the top of its respective major markets:
Innovative Medicines Division consists of two Business Units which focus on innovative medicine and protected patents: Pharma and Oncology
Alcon: specialises in eye care treatments and offers surgical, ophthalmological and consumer products
Sandoz: Sandoz offers a range of affordable yet high quality generics and biosimilars.